NASDAQ:IART

Integra Lifesciences Holdings Stock News

etoro logo Buy IART
*Your capital is at risk
$16.10
+0.430 (+2.74%)
At Close: Jun 03, 2026
Integra (IART) projects a severe impact on revenues due to the coronavirus-led economic crisis despite sequential improvement in monthly sales performance throughout the quarter.
Topline results from a retrospective study in 93 critically ill COVID-19 patients have become available. The data shows that IVIG treatment reduces in
ACell has filed to raise $75 million from an IPO of its common stock. The firm develops and sells various wound care products.
Octapharma announced today that new research findings from its haematology portfolio will be presented at the upcoming International Society on Thromb
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)...
PRINCETON, N.J., July 09, 2020 -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today certain unaudited.
Invivo Therapeutics (NASDAQ:NVIV) and Integra Lifesciences (NASDAQ:IART) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their
Morgan Stanley boosted its position in Integra Lifesciences Holdings Corp (NASDAQ:IART) by 202.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities &
An “adorable and friendly” feline who lost its tail in an unknown accident is lucky to be alive -- and she may be up for adoption soon.
New Mexico Educational Retirement Board increased its stake in shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) by 39.3% during the first quarter, according to its most recent Form 13F filin
Research initiated by RCSI and Beaumont Hospital to assess impact of treatment on critically ill
State of Tennessee Treasury Department lifted its holdings in shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) by 25.6% during the first quarter, according to the company in its most recent
We've talked before about the many types of regenerative medicines under development by a multitude of companies. Investors are pouring money into the burgeoning field of longevity of which regenerati
The Global Regenerative Medicine Market will grow by USD 9.55 bn during 2020-2024
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE